NCT06548763: Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
- State
- Not started
- Phase
- Phase 2
- People
- 30 planned
- Started
- 30 Nov 2024
- Primary completion
- 30 Jun 2026
- Arms
- Topotecanwith Terriptylimab
- Results
- None posted
- 12 Aug 2024: Trial registered